Are you in need a drug delivery system to bring your candidate molecules inside the cell? Are you tired of long and tedious collaborations? Can you imagine being able to arrive at the clinic with your candidate molecule? DIVERSA helps you with your drug delivery challenges.
DIVERSA is a spin-off of the Health Research Institute of Santiago de Compostela (IDIS) and the Servizo Galego de Saúde (SERGAS) established in January 2022. DIVERSA is the exclusive licensee of a new drug delivery technology based on lipid nanoemulsions for small drugs and macromolecules (peptides, proteins, and oligonucleotides), that increases their stability and therapeutic activity. Our ambition is clear: we want to be your trusted partner for drug delivery and pharmaceutical nanotechnology.
Some of the characteristics of our nanosystems are: their high loading capacity, biocompatibility, stability, versatility, and efficient intracellular delivery.
DIVERSA offers its technology in the form of "ready-to-go" kits for the entire research community (university laboratories and research centers that wants to continue advancing with its therapeutic molecules, CROs, and biotechnology and pharmaceutical companies).
It also offers co-development projects to biotechnology and pharmaceutical companies with the possibility of sublicensing the technology for specific indications. DIVERSA's technology is designed to be used both in vitro and in vivo. Plus, we can protect the commercialization of your molecule with our intellectual property.
In the European Union and the United Kingdom, we sell the kits through a distribution partner, the French company tebu-bio, and directly to the customer globally. The kits that are currently on the market allow the association of small drugs, peptides, and proteins. Over the course of the year, we plan to launch more products for the association of other types of molecules: messenger RNA, aptamers and antibodies. For more information visit our website www.diversatechnologies.com or send us an email to firstname.lastname@example.org.
Victor Francis, email@example.com